NCT02207426View on ClinicalTrials.gov

Pharmacokinetic and Pharmacoscintigraphic Comparison of TobrAir® 6.0 With TOBI® and TOBI® Podhaler™

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

September 30, 2014

Conditions
Healthy
Interventions
DRUG

Tobramycin

Trial Locations (1)

NG11 6JS

Quotient Clinical, Nottingham

Sponsors

Lead Sponsor

Pharmaero ApS
All Listed Sponsors
lead

Pharmaero ApS

INDUSTRY

NCT02207426 - Pharmacokinetic and Pharmacoscintigraphic Comparison of TobrAir® 6.0 With TOBI® and TOBI® Podhaler™ | Biotech Hunter | Biotech Hunter